LI
AMRX icon

Leap Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Leap Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-176,275
Closed -$511K – 418
2019
Q3 		$511K Buy
176,275
+109,579
+164% +$382K 0.25% 130
2019
Q2 		$478K Buy
+66,696
New +$682K 0.64% 44

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leap Investments's AMRX Position: Q4 2019 in Review

Leap Investments sold out of Amneal Pharmaceuticals (AMRX) in Q4 2019, closing a stake of 176,275 shares — an estimated $511K sold.

Leap Investments first reported a position in AMRX in Q2 2019 and held it in 2 quarters. The position peaked at $511K in Q3 2019. 129 funds tracked by Wall St. Rank hold AMRX as of Q4 2019.

  • Leap Investments reported no remaining Amneal Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 176,275 Amneal Pharmaceuticals shares in Q4 2019, an estimated $511K.
  • Leap Investments first reported a position in Amneal Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Leap Investments's Amneal Pharmaceuticals position peaked at $511K in Q3 2019.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.